AMAGX — Amana Mutual Funds Trust - Grow

Is AMAGX overbought or oversold? Here is the current MarketMoodz read.

FUND

Oversold As of November 17, 2026

Amana Mutual Funds Trust - Grow (AMAGX) currently reads Oversold on the MarketMoodz overbought/oversold meter, as of November 17, 2026. The FUND name last closed at $102.90. The rating moved from Neutral to Oversold on November 15, 2026.

See all oversold FUND stocks →

AI analysis

Amana Mutual Funds Trust - Grow (AMAGX) is positioned to capture upside in a mild risk-on environment given its growth-oriented equity mix and disciplined management. The fund benefits from diversification across growth names and a stable operational structure, supporting steady investor access and long-run performance potential. Without strong social or recent filing signals, outlook relies on macro/earnings continuation and active management to navigate volatility.

Key factors

  • Long-term growth orientation with equity exposure positioned to benefit from risk-on market sentiment
  • Experienced fund management and consistent investment process focused on quality growth companies
  • Diversified portfolio across growth sectors that have been favored in recent flows
  • Relative stability versus high-turnover strategies due to a focused, disciplined approach
  • Reasonable fee structure and liquidity typical of open-end mutual funds (supports investor access and retention)

Risks

  • Equity market volatility and sudden risk-off shifts could materially reduce NAV in the short term
  • Concentration in growth-oriented sectors could underperform during rate-driven rotations
  • Benchmark-relative performance risk if holdings lag larger-cap growth leaders
  • Limited available recent social/research signals to validate short-term sentiment shifts
  • Macroeconomic shocks or faster-than-expected rate moves that compress valuation multiples

See today's live rating, score and targets

Members see the live hourly rating for AMAGX — the numeric AI score plus targets and entry zones — while this public page updates nightly.

Start the 14-day trial

This page is for informational purposes only and is not investment, financial, tax, or legal advice. Ratings and research outputs can be wrong, incomplete, or stale. Past performance does not guarantee future results. Always do your own research and consider consulting a qualified professional.